查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435053

細胞和基因治療製造服務市場：按類型、適應症、應用和最終用戶 - 2024-2030 年全球預測

Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

細胞和基因治療製造服務市場規模預計2023年為173.4億美元，2024年達到199.8億美元，預計2030年將達到484.5億美元，複合年成長率為15.81%。

細胞和基因治療製造服務的全球市場

主要市場統計
基準年[2023] 173.4億美元
預測年份 [2024] 199.8億美元
預測年份 [2030] 484.5億美元
複合年成長率（%） 15.81%
細胞與基因治療製造服務市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估細胞和基因治療製造服務市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對細胞和基因治療製造服務市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-細胞和基因治療製造服務市場的市場規模和預測是多少？

2-在細胞和基因治療製造服務市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-細胞和基因治療製造服務市場的技術趨勢和法律規範是什麼？

4-細胞和基因治療製造服務市場主要供應商的市場佔有率是多少？

5-進入細胞和基因治療製造服務市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和其他目標疾病的發生率更高
      • CDMO加大對藥品研發及先進技術的投入
      • 專注於個人化醫療，疾病早期診斷的趨勢日益明顯
    • 抑制因素
      • 與細胞和基因治療製造服務相關的高營運成本
    • 機會
      • 細胞和基因療法開發中先進分析技術的出現
      • 改善細胞和基因治療製造的供應鏈
    • 任務
      • 細胞和基因治療製造中的品管和污染問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章細胞和基因治療製造服務市場：按類型

  • 細胞療法
    • 同種異體的
      • 同種異體造血幹細胞
      • 同種異體誘導性多功能幹細胞
      • 間質幹細胞
      • 同種異體自然殺手細胞
      • 同種異體T細胞
    • 自體的
      • 自體造血幹細胞
      • 間質幹細胞
      • 自體自然殺手細胞
      • 自體T細胞
    • 病毒載體
      • 腺結合病毒載體
      • 逆轉錄病毒載體
  • 基因治療
    • 非病毒載體
    • 寡核苷酸

第7章依適應症分類的細胞和基因治療製造服務市場

  • 心血管疾病
  • 中樞神經系統疾病
  • 感染疾病
  • 腫瘤疾病
  • 眼科疾病
  • 整形外科疾病

第8章細胞/基因治療製造服務市場：依應用分類

  • 臨床製造
  • 商業製造

第9章細胞與基因治療製造服務市場：依最終用戶分類

  • 學術研究所
  • 製藥和生物技術公司

第10章美洲細胞與基因治療製造服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞與基因治療製造服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的細胞和基因治療製造服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Bluebird Bio, Inc.
    • Boehringer Ingelheim International GmbH
    • c-LEcta GmbH
    • Catalent, Inc.
    • Cell and Gene Therapy Catapult
    • Cell Therapies Pty Ltd.
    • Charles River Laboratories International, Inc.
    • F. Hoffmann-La Roche Ltd.
    • FUJIFILM Holdings Corporation
    • Innovative Cellular Therapeutics Co., Ltd.
    • Lonza Group
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • Nikon Corporation
    • Novartis AG
    • Oxford Biomedica PLC
    • Samsung Biologics Co., Ltd
    • Showa Denko KK
    • Takara Bio Inc.
    • Thermo Fisher Scientific, Inc.
    • Wuxi Apptec Co., Ltd.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-BB6269D14168

[185 Pages Report] The Cell & Gene Therapy Manufacturing Services Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030.

Global Cell & Gene Therapy Manufacturing Services Market

KEY MARKET STATISTICS
Base Year [2023] USD 17.34 billion
Estimated Year [2024] USD 19.98 billion
Forecast Year [2030] USD 48.45 billion
CAGR (%) 15.81%
Cell & Gene Therapy Manufacturing Services Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell & Gene Therapy Manufacturing Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell & Gene Therapy Manufacturing Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell & Gene Therapy Manufacturing Services Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., Boehringer Ingelheim International GmbH, c-LEcta GmbH, Catalent, Inc., Cell and Gene Therapy Catapult, Cell Therapies Pty Ltd., Charles River Laboratories International, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, Innovative Cellular Therapeutics Co., Ltd., Lonza Group, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Nikon Corporation, Novartis AG, Oxford Biomedica PLC, Samsung Biologics Co., Ltd, Showa Denko K.K., Takara Bio Inc., Thermo Fisher Scientific, Inc., and Wuxi Apptec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cell & Gene Therapy Manufacturing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Cell Therapy
      • Allogeneic
        • Allogeneic Hematopoietic Stem Cells
        • Allogeneic Induced Pluripotent Stem Cells
        • Allogeneic Mesenchymal Stem Cells
        • Allogeneic Natural Killer Cells
        • Allogeneic T-cells
      • Autologous
        • Autologous Hematopoietic Stem Cells
        • Autologous Mesenchymal Stem Cells
        • Autologous Natural Killer Cells
        • Autologous T-cells
      • Viral Vector
        • Adeno-associated Virus Vectors
        • Retroviral Vectors
    • Gene Therapy
      • Non-viral Vector
      • Oligonucleotides
  • Indication
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Infectious Diseases
    • Oncology Diseases
    • Ophthalmology Diseases
    • Orthopedic Diseases
  • Application
    • Clinical Manufacturing
    • Commercial Manufacturing
  • End-User
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell & Gene Therapy Manufacturing Services Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell & Gene Therapy Manufacturing Services Market?

3. What are the technology trends and regulatory frameworks in the Cell & Gene Therapy Manufacturing Services Market?

4. What is the market share of the leading vendors in the Cell & Gene Therapy Manufacturing Services Market?

5. Which modes and strategic moves are suitable for entering the Cell & Gene Therapy Manufacturing Services Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell & Gene Therapy Manufacturing Services Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High Incidence of Cancer and Other Target Diseases
      • 5.1.1.2. Increasing Investments in Pharmaceutical R&D and Advanced Technologies by CDMOs
      • 5.1.1.3. Focus on the Personalized Medicine with the Rising Tendency Towards Early Disease Diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High Operational Costs Associated With Cell & Gene Therapy Manufacturing Services
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of Advanced Analytical Technologies in Development of Cell & Gene Therapy
      • 5.1.3.2. Improvement in the Supply Chain of Cell & Gene Therapy Manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Quality Control and Contamination Issues in Cell & Gene Therapy Production
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Cell & Gene Therapy Manufacturing Services Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Therapy
    • 6.3.1. Allogeneic
      • 6.3.2.1. Allogeneic Hematopoietic Stem Cells
      • 6.3.2.2. Allogeneic Induced Pluripotent Stem Cells
      • 6.3.2.3. Allogeneic Mesenchymal Stem Cells
      • 6.3.2.4. Allogeneic Natural Killer Cells
      • 6.3.2.5. Allogeneic T-cells
    • 6.3.2. Autologous
      • 6.3.3.1. Autologous Hematopoietic Stem Cells
      • 6.3.3.2. Autologous Mesenchymal Stem Cells
      • 6.3.3.3. Autologous Natural Killer Cells
      • 6.3.3.4. Autologous T-cells
    • 6.3.3. Viral Vector
      • 6.3.4.1. Adeno-associated Virus Vectors
      • 6.3.4.2. Retroviral Vectors
  • 6.3. Gene Therapy
    • 6.4.1. Non-viral Vector
    • 6.4.2. Oligonucleotides

7. Cell & Gene Therapy Manufacturing Services Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Central Nervous System Disorders
  • 7.4. Infectious Diseases
  • 7.5. Oncology Diseases
  • 7.6. Ophthalmology Diseases
  • 7.7. Orthopedic Diseases

8. Cell & Gene Therapy Manufacturing Services Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Manufacturing
  • 8.3. Commercial Manufacturing

9. Cell & Gene Therapy Manufacturing Services Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Cell & Gene Therapy Manufacturing Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell & Gene Therapy Manufacturing Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Bluebird Bio, Inc.
    • 14.1.2. Boehringer Ingelheim International GmbH
    • 14.1.3. c-LEcta GmbH
    • 14.1.4. Catalent, Inc.
    • 14.1.5. Cell and Gene Therapy Catapult
    • 14.1.6. Cell Therapies Pty Ltd.
    • 14.1.7. Charles River Laboratories International, Inc.
    • 14.1.8. F. Hoffmann-La Roche Ltd.
    • 14.1.9. FUJIFILM Holdings Corporation
    • 14.1.10. Innovative Cellular Therapeutics Co., Ltd.
    • 14.1.11. Lonza Group
    • 14.1.12. Merck KGaA
    • 14.1.13. Miltenyi Biotec B.V. & Co. KG
    • 14.1.14. Nikon Corporation
    • 14.1.15. Novartis AG
    • 14.1.16. Oxford Biomedica PLC
    • 14.1.17. Samsung Biologics Co., Ltd
    • 14.1.18. Showa Denko K.K.
    • 14.1.19. Takara Bio Inc.
    • 14.1.20. Thermo Fisher Scientific, Inc.
    • 14.1.21. Wuxi Apptec Co., Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET DYNAMICS
  • FIGURE 7. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 8. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 10. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC NATURAL KILLER CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC T-CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 17. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS NATURAL KILLER CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS T-CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 23. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 27. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY CELL